Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Prelude Therapeutics Inc (PRLD)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
24 May 2023
Lim Bryant David
Chief Legal Officer, Corp Sec., Officer
Prelude Therapeutics Inc
(PRLD)
2,400
+100%
2,400
$5.39
$12,936.00
BUY
24 May 2023
Vaddi Krishna
CEO, Director, Officer
Prelude Therapeutics Inc
(PRLD)
1,067,275
+0%
1,900
$5.15
$9,790.40
BUY
23 May 2023
Vaddi Krishna
CEO, Director, Officer
Prelude Therapeutics Inc
(PRLD)
1,065,375
+1%
11,856
$5.63
$66,749.28
BUY
23 May 2023
Chardonnet Laurent
Chief Financial Officer, Officer
Prelude Therapeutics Inc
(PRLD)
42,165
+13%
5,000
$5.50
$27,500.00
BUY
22 May 2023
Bonita David P
Director, 10% Owner
Prelude Therapeutics Inc
(PRLD)
10,119,756
+9%
869,565
$5.75
$4,999,999.00
BUY
22 May 2023
ORBIMED ADVISORS LLC
Director, 10% Owner
Prelude Therapeutics Inc
(PRLD)
10,119,756
+9%
869,565
$5.75
$4,999,999.00
SELL
4 Apr 2023
Huang Jane
President, CMO, Officer
Prelude Therapeutics Inc
(PRLD)
24,220
-35%
13,280
$6.12
$81,273.60
BUY
20 Dec 2022
Vaddi Krishna
CEO, Director, Officer
Prelude Therapeutics Inc
(PRLD)
120,665
+18%
19,188
$5.13
$98,445.95
BUY
8 Dec 2022
Chardonnet Laurent
Chief Financial Officer, Officer
Prelude Therapeutics Inc
(PRLD)
35,873
+38%
10,000
$4.76
$47,600.00
BUY
1 Jun 2022
Chardonnet Laurent
Chief Financial Officer, Officer
Prelude Therapeutics Inc
(PRLD)
24,500
+68%
10,000
$4.23
$42,300.00
SELL
15 Dec 2021
Morosini Deborah
EVP, Chief of Clinical Affairs, Officer
Prelude Therapeutics Inc
(PRLD)
444
-98%
28,751
$13.00
$373,763.00
BUY
13 Dec 2021
Combs Andrew
EVP, Head of Chemistry, Officer
Prelude Therapeutics Inc
(PRLD)
268,380
+3%
8,000
$11.86
$94,880.00
SELL
16 Nov 2021
Morosini Deborah
EVP, Chief of Clinical Affairs, Officer
Prelude Therapeutics Inc
(PRLD)
844
-97%
28,751
$15.88
$456,531.56
SELL
5 Oct 2021
Mauro David J
Chief Medical Officer, Officer
Prelude Therapeutics Inc
(PRLD)
9,092
-62%
15,000
$30.96
$464,349.94
SELL
7 Sep 2021
Mauro David J
Chief Medical Officer, Officer
Prelude Therapeutics Inc
(PRLD)
7,513
-66%
15,000
$36.69
$550,282.56
SELL
2 Sep 2021
Pierce Christopher
EVP and Chief of Business Oper, Officer
Prelude Therapeutics Inc
(PRLD)
17,407
-49%
17,000
$41.68
$708,492.70
SELL
26 Aug 2021
Scherle Peggy
Chief Scientific Officer, Officer
Prelude Therapeutics Inc
(PRLD)
176,234
-4%
7,714
$35.75
$275,786.75
SELL
25 Aug 2021
Piper Brian
Chief Financial Officer, Officer
Prelude Therapeutics Inc
(PRLD)
6,233
-57%
8,333
$33.34
$277,827.44
SELL
13 Aug 2021
Scherle Peggy
Chief Scientific Officer, Officer
Prelude Therapeutics Inc
(PRLD)
172,920
-1%
2,286
$35.07
$80,161.34
SELL
5 Aug 2021
Mauro David J
Chief Medical Officer, Officer
Prelude Therapeutics Inc
(PRLD)
8,884
-62%
15,000
$31.09
$466,394.20
SELL
27 Jul 2021
Scherle Peggy
Chief Scientific Officer, Officer
Prelude Therapeutics Inc
(PRLD)
173,600
-10%
20,000
$35.47
$709,379.94
SELL
6 Jul 2021
Mauro David J
Chief Medical Officer, Officer
Prelude Therapeutics Inc
(PRLD)
4,555
-76%
15,000
$27.47
$412,107.03
SELL
7 Jun 2021
Mauro David J
Chief Medical Officer, Officer
Prelude Therapeutics Inc
(PRLD)
13,600
-52%
15,000
$32.44
$486,622.34
SELL
25 May 2021
Piper Brian
Chief Financial Officer, Officer
Prelude Therapeutics Inc
(PRLD)
5,223
-61%
8,333
$34.27
$285,537.22
SELL
7 May 2021
Scherle Peggy
Chief Scientific Officer, Officer
Prelude Therapeutics Inc
(PRLD)
178,956
-5%
10,000
$40.82
$408,192.28
SELL
5 May 2021
Mauro David J
Chief Medical Officer, Officer
Prelude Therapeutics Inc
(PRLD)
11,585
-56%
15,000
$40.14
$602,091.90
SELL
29 Apr 2021
Pierce Christopher
EVP and Chief of Business Oper, Officer
Prelude Therapeutics Inc
(PRLD)
3,750
-46%
3,295
$40.29
$132,764.78
SELL
29 Apr 2021
Morosini Deborah
EVP, Chief of Clinical Affairs, Officer
Prelude Therapeutics Inc
(PRLD)
444
-87%
3,223
$40.29
$129,853.38
SELL
27 Apr 2021
Mauro David J
Chief Medical Officer, Officer
Prelude Therapeutics Inc
(PRLD)
17,312
-59%
25,000
$35.39
$884,847.80
SELL
19 Apr 2021
Mauro David J
Chief Medical Officer, Officer
Prelude Therapeutics Inc
(PRLD)
4,000
-86%
25,000
$30.89
$772,349.30
SELL
8 Apr 2021
Scherle Peggy
Chief Scientific Officer, Officer
Prelude Therapeutics Inc
(PRLD)
176,133
-2%
4,630
$38.34
$177,503.90
SELL
8 Apr 2021
Mauro David J
Chief Medical Officer, Officer
Prelude Therapeutics Inc
(PRLD)
6,343
-60%
9,617
$38.35
$368,852.28
SELL
8 Apr 2021
Pierce Christopher
EVP and Chief of Business Oper, Officer
Prelude Therapeutics Inc
(PRLD)
3,750
-5%
200
$40.00
$8,000.00
SELL
8 Apr 2021
Morosini Deborah
EVP, Chief of Clinical Affairs, Officer
Prelude Therapeutics Inc
(PRLD)
444
-18%
100
$40.00
$4,000.00
SELL
7 Apr 2021
Scherle Peggy
Chief Scientific Officer, Officer
Prelude Therapeutics Inc
(PRLD)
180,001
-7%
15,370
$39.31
$604,144.20
SELL
7 Apr 2021
Mauro David J
Chief Medical Officer, Officer
Prelude Therapeutics Inc
(PRLD)
7,083
-68%
15,383
$39.33
$605,023.25
SELL
7 Apr 2021
Pierce Christopher
EVP and Chief of Business Oper, Officer
Prelude Therapeutics Inc
(PRLD)
3,750
-18%
828
$40.08
$33,188.39
SELL
7 Apr 2021
Morosini Deborah
EVP, Chief of Clinical Affairs, Officer
Prelude Therapeutics Inc
(PRLD)
444
-69%
1,000
$40.04
$40,043.00
BUY
29 Sep 2020
Dier Mardi
Director
Prelude Therapeutics Inc
(PRLD)
10,000
+100%
10,000
$19.00
$190,000.00
BUY
29 Sep 2020
Pierce Christopher
EVP and Chief of Business Oper, Officer
Prelude Therapeutics Inc
(PRLD)
3,750
+100%
3,750
$19.00
$71,250.00
BUY
29 Sep 2020
Combs Andrew
EVP, Head of Chemistry, Officer
Prelude Therapeutics Inc
(PRLD)
260,380
+0%
1,000
$19.00
$19,000.00
BUY
29 Sep 2020
Morosini Deborah
EVP, Chief of Clinical Affairs, Officer
Prelude Therapeutics Inc
(PRLD)
444
+100%
444
$19.00
$8,436.00
BUY
25 Sep 2020
ORBIMED ADVISORS LLC
Director, 10% Owner
Prelude Therapeutics Inc
(PRLD)
526,300
+174%
1,236,800
$19.00
$23,499,200.00
BUY
27 Mar 2020
BAKER BROS. ADVISORS LP
Director, 10% Owner
Prelude Therapeutics Inc
(PRLD)
870,873
+222%
1,578,947
$19.00
$29,999,992.00
BUY
27 Mar 2020
Bonita David P
Director, 10% Owner
Prelude Therapeutics Inc
(PRLD)
526,300
+174%
1,236,800
$19.00
$23,499,200.00
Home